Literature DB >> 28115076

Cognitive Bias and the Creation and Translation of Evidence Into Clinical Practice.

Donald A Molony1.   

Abstract

The optimal translation of evidence into the clinical practice of nephrology follows validated evidence-based medicine (EBM) principles. Most importantly, the evidence-based medicine practitioner requires that the evidence, as much as possible, addresses in an unbiased manner clinical questions of importance to patients and reflects the truth. In this chapter, we evaluate how cognitive biases that affect medical decision making might systematically bias the overall management of patients with kidney disease and, thus, distort the observations about disease causation, prognosis, diagnosis, and management that are derived from analysis of administrative databases or electronic medical records of health care systems. These cognitive biases influence how questions are framed, how risk factors and health status are measured, how decisions are made, and what actions are implemented. We explore the nature of these biases and the possible places where such biases are most likely to distort clinical care and the collection of the data that is used to inform clinical practice in nephrology. To the extent that cognitive biases selectively modify diagnostic interrogations and therapeutic interventions in some patients, the resultant databases may provide a skewed picture of the health of the nephrology patient population and should be considered with some skepticism when exploited to achieve best practice.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive bias; Evidence-based medicine; Research methodologies

Mesh:

Year:  2016        PMID: 28115076     DOI: 10.1053/j.ackd.2016.11.018

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  1 in total

1.  Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices.

Authors:  Raffaella Ravinetto; Céline Caillet; Muhammad H Zaman; Jerome Amir Singh; Philippe J Guerin; Aasim Ahmad; Carlos E Durán; Amar Jesani; Ana Palmero; Laura Merson; Peter W Horby; E Bottieau; Tammy Hoffmann; Paul N Newton
Journal:  BMC Med Ethics       Date:  2021-07-28       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.